11-Beta-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors in Type 2 diabetes mellitus and obesity

Katherine A Hughes, Scott P Webster, Brian R Walker
  • Expert Opinion on Investigational Drugs, March 2008, Informa Healthcare
  • DOI: 10.1517/13543784.17.4.481
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Dr Scott P Webster